ArticleCureus2025
Prevalence of Metabolic Syndrome Among Individuals With Spinal Cord Injury: A Cross-Sectional Analysis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study aimed to investigate the prevalence of metabolic syndrome (MetS) among patients with spinal cord injury (SCI) and its correlation with clinical parameters.
methodsThis was a comprehensive assessment involving 100 inpatient SCI rehabilitation participants from January 2010 to December 2011. Demographic details, disease duration, and neurological evaluations following the American Spinal Injury Association (ASIA) criteria were recorded. Diagnosis of MetS adhered to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria. Measurements including height, weight, waist circumference, blood pressure, and body fat percentages were taken using standardized methodologies. Biochemical analyses involved fasting blood samples for glucose, high-density lipoprotein (HDL), total cholesterol, and triglyceride levels. Functional evaluations utilized the Functional Independence Measure (FIM) for assessing daily living activities and the Walking Index for Spinal Cord Injury (WISCI) to evaluate ambulation status.
resultsA total of 42 (42%) patients had MetS. The MetS group had longer disease duration (p=0.007). Female patients showed lower waist circumference, body fat, FIM and WISCI scores, and BMI compared to male patients (p=0.01, 0.00, 0.03, 0.04, 0.04, respectively). MetS varied between tetraplegic 14% (n=3) and paraplegic patients 50% (n=39) (p=0.0059), with distinct differences in waist circumference, body fat, FIM and WISCI scores, and BMI (p=0.04, 0.00, 0.00, 0.01, 0.01, respectively). ASIA scores didn't significantly relate to MetS. While body weight differed in MetS (p < 0.0001), no associations were found with FIM and WISCI scores, height, or BMI. Patients with MetS had higher body fat (p = 0.018), but no strong links with FIM or WISCI scores (p = 0.077, 0.275, respectively).
conclusionSCI patients show heightened cardiovascular risks, with increasing MetS frequency linked to older age and longer injury duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.